EXEDRA, an EXpansion of the European Joint Programming Initiative on Drug Resistance to Antimicrobials, will build on, and further support the structure and activities of JPIAMR to address the two major objectives of HCO-04-2016 topic: extending JPIAMR globally and creating a long-term sustainable structure for future expansion and governance which will coordinate national funding and collaborative actions supporting the implementation of the JPIAMR Strategic Research Agenda (SRA). JPIAMR EXEDRA will be the second Coordinated Support Action (CSA) for this Joint Programming Initiative (JPI) and essentially build on the work of the first CSA (JPIAMR), which ended February 2016. It will provide a strong support structure for the JPIAMR during the forthcoming implementation and expansion phaseby maintaining a continuity between the objectives, tasks and Work Packages of EXEDRA and JPIAMR. Support facilitated by the CSA EXEDRA will ensure that the ethos of joint programming in the area antimicrobial drug resistance becoming embedded within JPIAMR member’s research and innovation policies and programmes. EXEDRA will have the following work packages: WP1 Management and coordination; WP2 Strategy, governance, and long term sustainability; WP3 Internationalisation and capacity extension; WP4 Alignment with policy and industry; WP5 Research alignment; WP6 Communication, dissemination, and advocacy. EXEDRA will significantly contribute to the delivery of the JPIAMR SRA combined with the JPI-EC-AMR effort and the experience of the JPIAMR members. EXEDRA (and the JPIAMR) will support transnational cooperation to to pool substantial and long-term research funding and serve to complement other initiatives in the AMR area. It will create momentum with the potential to move the frontiers forward and offer new opportunities for industry, new tools for society, and new evidence-based data for policy makers, which will inspire other necessary initiatives.

The overall aim of JPsustaiND is to support the development and extension of the capacities of the EU Joint Programming Initiative on Neurodegenerative Diseases, in particular Alzheimer's (JPND). Since 2009 JPND has been operating on a very light management structure based on a simple Terms of Reference. Through this JPND has been able to set a common Strategic Research Agenda, and to deliver its first implementation plan that has allowed among other achievements, the mobilisation of approximately €100 million of additional funding between 2011 and 2015 to support transnational research programs. While progress has been pleasing to date, the implementation of JPND must now be scaled-up to further catalyse Member State commitments, and to formalize synergies between members and various partners. The immediate challenge therefore for JPND is to secure its long-term sustainability by Member States, to mobilize those which are not yet participating, and to increase its impact at the national level and globally. JPsustaiND thus aims at creating the dedicated structure responsible for long-term JPND management and implementation, and extension of JPND membership to EU Member States and other countries and initiatives not yet participating. To achieve this goal, the JPsustaiND partners, with the support of the JPND Management Board, will implement the following six workpackages: Coordination and Management; Long Term Sustainability; Capacity Extension; Alignment and Outreach; Communication and Advocacy; and Monitoring, Evaluation and Impact Assessment. JPsustaiND will implement a stronger global dimension of the JPND, and will avoid duplication of research and infrastructure investment at the national level. By supporting further coordination and integration of national research and innovation programmes with the JPND research strategy, in coherence with Horizon 2020 objectives, JPsustaiND is thus creating a dedicated European Research Area for neurodegenerative diseases.

Joint Programming is a process combining a strategic framework, a bottom-up approach and high-level commitment from the Member States (MS). It builds on the experience gained from existing schemes, coordinating national programmes by contributing to the reduction in fragmentation of research efforts of MS, stepping up the mobilisation of skills, knowledge and resources, advancing research and innovation in the specific field. The JPI in "Cultural Heritage and Global Change: a new Challenge for Europe" - JPICH - was approved by the Council was launched in January 2010. The JPICH has defined the Vision Document, the Terms of Reference, the Strategic Research Agenda (SRA), an Action Programme and a monitoring and evaluation procedure. The experience gained over the past 4 years in JPICH development and implementation has been achieved through the active participation of 17 EU MS and AC and 8 Countries participating with the role of Observers. The present CSA JHEP2 Proposal intends to support the implementation of the Strategic Research Agenda following the recommendations emerging from the High level Group for joint programming (GPC) in the Biennial Report 2014 and in the Report on "Alignment in the context of Joint Programming", which specifically address the recommendation to develop alignment of national research and innovation programmes and activities and application of qualitative and quantitative Key Performance Indicators (KPIs).The main objectives addressed within the present proposal are: - Develop effective and efficient governance of the alignment of the national research and innovation programmes. - Reinforce common activities on cultural heritage. - Apply quantitative and qualitative KPIs for monitoring an assessing the JPICH alignment process. The support to the JPICH with the present JHEP2 Proposal will be essential for achieving the above-mentioned objectives and proceed with the integration of the research area on Cultural Heritage.

The objective of the NCP_WIDE.NET is to create a transnational network of National Contact Points (NCPs) for Spreading Excellence and Widening Participation under Horizon 2020 in order to facilitate trans-national co-operation between NCPs, with a view to identifying and sharing good practices and raising the general standards of support to applicants, taking into account the diversity of actors, including newcomers, that make up the constituency of WIDESPREAD part. Project is targeted towards the Widespread NCP Forum - officially nominated WIDESPREAD NCPs in EU Member States and Associated Countries - including experienced and less experienced NCPs. Expected impacts of the proposal aiming at ensuring quality standards of services, lowering entry barriers and increased applications to Horizon 2020 will be reached through a portfolio of dedicated meassures. The overall logic of the proposal is based on the improving and leveling of the NCPs capacities to deliver services of high quality standards, enhancing transnational collaboration between applicants, delivering complex information on WIDESPREAD activities and promoting the Network itself. The implementation of the proposal includes following tailored actions: internal trainings and mentoring based on benchmarking, support to WIDESPREAD expertise through development of guides and reports, transnational collaborative events for stakeholders such s brokerage events and joint workshops, actions dedicated to newcomers, networking activates, dissemination actions, complex source of information (Project Portal one-stop-shop) and promotion activities. Proposal addresses the work programme in terms of supporting and leveling NCPs capacity in delivering services of high quality standards. The project will contribute to more balanced development of ERA, spreading of excellence in research in all European regions and widening participation of research centers and stakeholders from weaker regions in H2020.

Cardiovascular diseases (CVD) are the largest cause of death in the EU and account for around 2 million deaths per year. Overall, CVD are estimated to cause the economy of the EU costs of almost 196 billion Euros a year. Furthermore, they are one of the leading causes of long term sickness, chronic diseases and loss to the labour market. Therefore, CVD are a major health problem in Europe. Despite the overall burden of CVD on European citizens and national health systems, translational cardiovascular research is fragmented and mainly occurs at national levels. However, the present and future challenges in cardiovascular research can only be met by an effective cooperation at transnational level. Therefore, the proposed European Research Area Network on cardiovascular diseases (ERA-CVD) aims to coordinate national and regional programmes for translational research in the area CVD by implementing one Joint Transnational Call (JTC2016) with EU Co-funding followed by further non-co-funded JTC (2017-2019). Although this consortium will be newly established, a collaboration and alignment of national programmes and activities has already been achieved during the preparation of the ERA-Net Co-fund proposal. This process is supported by CardioScape an EU-funded survey of the European cardiovascular research landscape coordinated by the European Society of Cardiology (ESC). The current ERA-CVD proposal will extend and strengthen the transnational cooperation of the current 23 ministries/institutions/foundations from 18 European, associated and third countries. Furthermore, ERA-CVD plans to cooperate with the ESC and the European Heart Network (EHN). Moreover, the collaboration with European Research Infrastructures, e.g. the ESFRI-initiatives is intended in order to set up an efficient European framework for innovative transnational research on CVD. Also the extension of the consortium and international collaborations are intended.